workflow:
  id: workflow_biotech_crispr_therapy
  title: Biotechnology CRISPR Therapy Development
  department: R&D
  complexity: complex
  participants:
  - Research Director
  - Molecular Biologist
  - Bioinformatics Specialist
  - Regulatory Affairs
  - Clinical Development Lead
  - IP Counsel
  trigger: CRISPR target identification and validation completed
  steps:
  - step: 1
    actor: Research Director
    action: Design CRISPR-based therapeutic approach including guide RNA selection
      and delivery method
    tools:
    - CRISPR design software
    - Gene editing databases
    - Molecular modeling tools
    duration: 12 weeks
    outputs:
    - Therapeutic design document
    - Initial safety assessment
  - step: 2
    actor: Molecular Biologist
    action: Validate CRISPR editing efficiency and specificity in cell culture models
    tools:
    - Cell culture facilities
    - Gene sequencing equipment
    - Flow cytometry
    duration: 16 weeks
    outputs:
    - In vitro validation data
    - Editing efficiency reports
  - step: 3
    actor: Bioinformatics Specialist
    action: Analyze off-target effects and optimize guide RNA design using computational
      models
    tools:
    - Bioinformatics pipelines
    - Machine learning algorithms
    - Genome databases
    duration: 8 weeks
    outputs:
    - Off-target analysis report
    - Optimized guide RNA sequences
  - step: 4
    actor: IP Counsel
    action: Conduct patent landscape analysis and file provisional patent applications
    tools:
    - Patent databases
    - IP management software
    - Legal research platforms
    duration: 6 weeks
    outputs:
    - Patent landscape report
    - Provisional patent filings
  - step: 5
    actor: Regulatory Affairs
    action: Prepare regulatory strategy and initial IND-enabling studies plan
    tools:
    - Regulatory databases
    - Toxicology study protocols
    - Clinical trial design software
    duration: 10 weeks
    outputs:
    - Regulatory strategy document
    - IND-enabling study protocols
  - step: 6
    actor: Clinical Development Lead
    action: Develop clinical development plan including Phase 1 trial design and patient
      selection criteria
    tools:
    - Clinical trial management systems
    - Patient registry databases
    - Statistical analysis software
    duration: 12 weeks
    outputs:
    - Clinical development plan
    - Phase 1 trial protocol
  success_criteria: IND application submitted with compelling preclinical data package
  failure_modes:
  - High off-target editing rates
  - Immune response to delivery system
  - Regulatory pathway uncertainty
  metrics:
  - 'Editing efficiency: >80% on-target modification'
  - 'Off-target effects: <0.1% frequency'
  - 'Patent filings: 5+ provisional applications'
  - 'Regulatory milestones: IND submission within 18 months'
